249 related articles for article (PubMed ID: 37868988)
1. Combined signature of N7-methylguanosine regulators with their related genes and the tumor microenvironment: a prognostic and therapeutic biomarker for breast cancer.
Li T; Chen Z; Wang Z; Lu J; Chen D
Front Immunol; 2023; 14():1260195. PubMed ID: 37868988
[TBL] [Abstract][Full Text] [Related]
2. Integrative pan-cancer analysis and clinical characterization of the N7-methylguanosine (m7G) RNA modification regulators in human cancers.
He CM; Zhang XD; Zhu SX; Zheng JJ; Wang YM; Wang Q; Yin H; Fu YJ; Xue S; Tang J; Zhao XJ
Front Genet; 2022; 13():998147. PubMed ID: 36226166
[No Abstract] [Full Text] [Related]
3. Development of a novel prognostic signature based on single-cell combined bulk RNA analysis in breast cancer.
Xiao Y; Hu G; Xie N; Yin L; Pan Y; Liu C; Lou S; Zhu C
J Gene Med; 2024 Feb; 26(2):e3673. PubMed ID: 38404059
[TBL] [Abstract][Full Text] [Related]
4. Identification of m7G-associated lncRNA prognostic signature for predicting the immune status in cutaneous melanoma.
Rong J; Wang H; Yao Y; Wu Z; Chen L; Jin C; Shi Z; Wu C; Hu X
Aging (Albany NY); 2022 Jun; 14(12):5233-5249. PubMed ID: 35771136
[TBL] [Abstract][Full Text] [Related]
5. Construction of prognostic signature of breast cancer based on N7-Methylguanosine-Related LncRNAs and prediction of immune response.
Cao J; Liang Y; Gu JJ; Huang Y; Wang B
Front Genet; 2022; 13():991162. PubMed ID: 36353118
[No Abstract] [Full Text] [Related]
6. N7-methylguanosin regulators-mediated methylation modification patterns and characterization of the immune microenvironment in lower-grade glioma.
Maimaiti A; Feng Z; Liu Y; Turhon M; Xie Z; Baihetiyaer Y; Wang X; Kasimu M; Jiang L; Wang Y; Wang Z; Pei Y
Eur J Med Res; 2023 Mar; 28(1):144. PubMed ID: 36998056
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of N
Li J; Zheng L; Song L; Dong Z; Bai W; Qi L
J Cell Mol Med; 2024 Jan; 28(2):e18067. PubMed ID: 38071502
[TBL] [Abstract][Full Text] [Related]
8. m7G-related gene NUDT4 as a novel biomarker promoting cancer cell proliferation in lung adenocarcinoma.
Liu Y; Jiang B; Lin C; Zhu W; Chen D; Sheng Y; Lou Z; Ji Z; Wu C; Wu M
Front Oncol; 2022; 12():1055605. PubMed ID: 36761423
[TBL] [Abstract][Full Text] [Related]
9. M7G methylated core genes (METTL1 and WDR4) and associated RNA risk signatures are associated with prognosis and immune escape in HCC.
Li R; Liu X; Deng K; Wang X
BMC Med Genomics; 2023 Aug; 16(1):179. PubMed ID: 37528384
[TBL] [Abstract][Full Text] [Related]
10. A novel m7G regulator-based methylation patterns in head and neck squamous cell carcinoma.
Ying Y; Zhang W; Zhu H; Luo J; Xu X; Yang S; Zhao Y; Zhang Z
Mol Carcinog; 2023 Dec; 62(12):1902-1917. PubMed ID: 37642290
[TBL] [Abstract][Full Text] [Related]
11. N7-methylguanosine regulatory genes well represented by METTL1 define vastly different prognostic, immune and therapy landscapes in adrenocortical carcinoma.
Xu F; Cai D; Liu S; He K; Chen J; Qu L; Chong T; Li X; Ren B
Am J Cancer Res; 2023; 13(2):538-568. PubMed ID: 36895966
[TBL] [Abstract][Full Text] [Related]
12. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
13. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma.
Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J
BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719
[TBL] [Abstract][Full Text] [Related]
14. Tumor immune microenvironment-based clusters in predicting prognosis and guiding immunotherapy in breast cancer.
Liu Y; He X; Yang YI
J Biosci; 2024; 49():. PubMed ID: 38287674
[TBL] [Abstract][Full Text] [Related]
15. Constructing and validating of m7G-related genes prognostic signature for hepatocellular carcinoma and immune infiltration: potential biomarkers for predicting the overall survival.
Liu P; Dong C; Shi H; Yan Z; Zhang J; Liu J
J Gastrointest Oncol; 2022 Dec; 13(6):3169-3182. PubMed ID: 36636051
[TBL] [Abstract][Full Text] [Related]
16. Expression pattern and prognostic value of key regulators for N7-methylguanosine RNA modification in prostate cancer.
Zhai Q; Hou Y; Ye Y; Dai S; Guo G; Yang Q; Pang G; Wei Q
Acta Biochim Biophys Sin (Shanghai); 2023 Feb; 55(4):561-573. PubMed ID: 36810782
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns and prognostic value of key regulators associated with m7G RNA modification based on all gene expression in colon adenocarcinoma.
Zhu Y; Zhao Z; Thandar M; Cheng J; Chi P; Huang S
BMC Gastroenterol; 2023 Jan; 23(1):22. PubMed ID: 36681801
[TBL] [Abstract][Full Text] [Related]
18. Analysis of m7G-Related signatures in the tumour immune microenvironment and identification of clinical prognostic regulators in breast cancer.
Huang Q; Mo J; Yang H; Ji Y; Huang R; Liu Y; Pan Y
BMC Cancer; 2023 Jun; 23(1):583. PubMed ID: 37353728
[TBL] [Abstract][Full Text] [Related]
19. Identification of N7-methylguanosine related subtypes and construction of prognostic model in gastric cancer.
Li X; Dong H; Chen L; Wang Y; Hao Z; Zhang Y; Jiao Y; Zhao Z; Peng X; Zhan X
Front Immunol; 2022; 13():984149. PubMed ID: 36300121
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk of RNA methylation writers defines tumor microenvironment and alisertib resistance in breast cancer.
Zhang X; Shen L; Zhu Y; Zhai C; Zeng H; Liu X; Tao J
Front Endocrinol (Lausanne); 2023; 14():1166939. PubMed ID: 37818090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
